These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8904132)

  • 21. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
    Takeuchi H; Ikoma H; Suzuki T; Nakajima M; Kouzaki Y; Ishizu Y; Makino H; Sugihara S; Ootawara S; Asagi K
    Jpn J Antibiot; 1994 Jan; 47(1):84-92. PubMed ID: 8114275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.
    Stevens DL; Pien F; Drehobl M
    Diagn Microbiol Infect Dis; 1993 Feb; 16(2):123-9. PubMed ID: 8467623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacterial infections of the respiratory tract and of the ENT area. Cephalosporin in general practice is effective].
    Hanke K; Blum SP
    MMW Fortschr Med; 2002 Mar; 144(13):36. PubMed ID: 12001587
    [No Abstract]   [Full Text] [Related]  

  • 24. Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media.
    Mendelman PM; Del Beccaro MA; McLinn SE; Todd WM
    J Pediatr; 1992 Sep; 121(3):459-65. PubMed ID: 1517926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
    Haruta T; Kuroki S; Hashimoto N; Suzuki N; Okura K; Kobayashi Y
    Jpn J Antibiot; 1989 Jul; 42(7):1621-8. PubMed ID: 2562790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia.
    Zuck P; Rio Y; Ichou F
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():71-7. PubMed ID: 2292534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis.
    Gehanno P; Depondt J; Barry B; Simonet M; Dewever H
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():87-91. PubMed ID: 2127269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on cefpodoxime proxetil in the pediatric fields].
    Watanabe A; Koshinami M
    Jpn J Antibiot; 1989 Jul; 42(7):1471-6. PubMed ID: 2810723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic study and clinical evaluation of cefpodoxime proxetil in the elderly with impaired renal function.
    Ishioka T
    J Chemother; 1995 Nov; 7 Suppl 4():122-3. PubMed ID: 8904130
    [No Abstract]   [Full Text] [Related]  

  • 30. [Overall clinical evaluation of cefpodoxime proxetil against infections in pediatric fields].
    Fujii R; Meguro H; Arimasu O; Shiraishi H; Abe T; Yoshioka H; Sakata H; Iseki K; Takahashi Y; Murono K
    Jpn J Antibiot; 1989 Jul; 42(7):1439-55. PubMed ID: 2681863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The influence of cefpodoxime proxetil on the intestinal bacterial flora].
    Iwata S; Yamada K; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Nanri S; Oikawa T; Sunakawa K
    Jpn J Antibiot; 1989 Jul; 42(7):1667-84. PubMed ID: 2681865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Observational study of the tolerance and effectiveness of cefpodoxim-proxetil in general practice].
    Hanke K; Blum SP
    Fortschr Med Orig; 2002; 120(1):21-8. PubMed ID: 14518354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of cefpodoxime proxetil in the pediatric field].
    Niino K; Sato H; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Nakazawa S
    Jpn J Antibiot; 1989 Jul; 42(7):1505-18. PubMed ID: 2810727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of a new oral cephem, cefpodoxime proxetil in children].
    Meguro H; Arimasu O; Shiraishi H; Tajima T; Hiruma F; Nishimura S; Sugie N; Sugamata K; Abe T; Fujii R
    Jpn J Antibiot; 1989 Jul; 42(7):1561-70. PubMed ID: 2810730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of cefpodoxime in the prophylaxis of recurrent pharyngotonsillitis.
    Mora R; Salami A; Mora F; Cordone MP; Ottoboni S; Passali GC; Barbieri M
    Int J Pediatr Otorhinolaryngol; 2003 Dec; 67 Suppl 1():S225-8. PubMed ID: 14662201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
    Safran C
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and pharmacokinetic evaluation of cefpodoxime proxetil in children].
    Sakata H; Kakehashi H; Fujita K; Yoshioka H; Iseki K; Murono K; Takahashi Y
    Jpn J Antibiot; 1989 Jul; 42(7):1456-63. PubMed ID: 2810721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [(New antimicrobial agent series XLIV): cefpodoxime proxetil].
    Kumazawa J
    Jpn J Antibiot; 1993 Sep; 46(9):749-72. PubMed ID: 8254896
    [No Abstract]   [Full Text] [Related]  

  • 39. Cefpodoxime proxetil in the treatment of skin and soft tissue infections.
    Tack KJ; Wilks NE; Semerdjian G; Frazier CH; Shirin K; Puopolo A; Crossland SG; Goffe BS; Millikan L
    Drugs; 1991; 42 Suppl 3():51-6. PubMed ID: 1726208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs recently released in Belgium. Cefpodoxime proxetil--Fosinopril.
    Harvengt C
    Acta Clin Belg; 1993; 48(4):284-7. PubMed ID: 8212980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.